{"product_id":"european-association-of-dermato-oncology-11th-world-congress-of-melanoma-and-21st-eado-congress-2025","title":"European Association of Dermato-Oncology 11th World Congress of Melanoma and 21st EADO Congress 2025","description":"\u003cul\u003e\n  \u003cli\u003eTarget Audience: dermatologists, oncologists, surgeons, and pathologists specializing in skin cancer\u003c\/li\u003e\n  \u003cli\u003eSample video: contact me for sample video\u003c\/li\u003e\n  \u003cli\u003eInformation:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eThe 11th World Congress of Melanoma combined with the 21st EADO Congress 2025 is a premier international event uniting specialists from around the globe to advance knowledge and practice in dermato-oncology. This congress offers a rich scientific program with plenary sessions, interactive symposia, workshops, and case-based learning covering every aspect of melanoma and skin cancer management.\u003c\/p\u003e\n\u003cp\u003eWhat You Will Learn\u003c\/p\u003e\n\u003cp\u003eLatest advances in prevention, diagnosis, staging, and treatment of melanoma and other skin cancers\u003c\/p\u003e\n\u003cp\u003eInnovative surgical and non-surgical therapies, including immunotherapy and targeted treatments\u003c\/p\u003e\n\u003cp\u003eCase-based discussions focusing on complex and rare cutaneous tumors\u003c\/p\u003e\n\u003cp\u003eAdvocacy and public health sessions addressing awareness, screening, and patient engagement\u003c\/p\u003e\n\u003cp\u003eEvent Details\u003c\/p\u003e\n\u003cp\u003eLocation: Megaron Athens International Conference Centre, Athens, Greece\u003c\/p\u003e\n\u003cp\u003eWho Should Attend\u003c\/p\u003e\n\u003ch3\u003eThis congress is ideal for:\u003c\/h3\u003e\n\u003cp\u003eDermatologists, oncologists, surgeons, and pathologists specializing in skin cancer\u003c\/p\u003e\n\u003cp\u003eResearchers and clinicians seeking the latest scientific updates in dermato-oncology\u003c\/p\u003e\n\u003cp\u003eResidents and fellows aiming to expand their expertise and network with world leaders in the field\u003c\/p\u003e\n\u003cp\u003eHealthcare advocates interested in advancing melanoma awareness and policy\u003c\/p\u003e\n\u003cp\u003eWhy Attend\u003c\/p\u003e\n\u003cp\u003eGain cutting-edge knowledge from international experts across multiple specialties\u003c\/p\u003e\n\u003cp\u003eParticipate in highly interactive and practical learning sessions\u003c\/p\u003e\n\u003cp\u003eNetwork with peers and key opinion leaders in a dynamic, global environment\u003c\/p\u003e\n\u003cp\u003eExperience an inspiring educational program in one of Europe’s most historic and vibrant cities\u003c\/p\u003e\n\u003cul\u003e\n  \u003cli\u003eTopics:\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eCLOSING.mp4\u003c\/p\u003e\n\u003cp\u003eDERMOSCOPY CONTEST I.mp4\u003c\/p\u003e\n\u003cp\u003eDERMOSCOPY CONTEST II.mp4\u003c\/p\u003e\n\u003cp\u003eFinal_Programm_WCM2025_V5.pdf\u003c\/p\u003e\n\u003cp\u003eFREE COMMUNICATION I Melanoma – systemic therapy other than ICI therapy.mp4\u003c\/p\u003e\n\u003cp\u003eFREE COMMUNICATION II Squamous cell carcinoma + rare tumors.mp4\u003c\/p\u003e\n\u003cp\u003eFREE COMMUNICATION III Melanoma – Epidemiology and diagnostics.mp4\u003c\/p\u003e\n\u003cp\u003eFREE COMMUNICATION IV Melanoma – Experimental and translational studies.mp4\u003c\/p\u003e\n\u003cp\u003eFREE COMMUNICATION V Melanoma – Surgery.mp4\u003c\/p\u003e\n\u003cp\u003eFREE COMMUNICATION VI Basal cell carcinoma.mp4\u003c\/p\u003e\n\u003cp\u003eFREE COMMUNICATION VII Melanoma – Immune checkpint inhibitor (ICI) therapy.mp4\u003c\/p\u003e\n\u003cp\u003eKEYNOTE LECTURE KEY02 The journey from melanocytes to melanoma.mp4\u003c\/p\u003e\n\u003cp\u003eKEYNOTE LECTURE KEY03 Diagnostic tools for skin cancer detection beyond dermoscopy.mp4\u003c\/p\u003e\n\u003cp\u003eKEYNOTE LECTURE KEY04 New diagnostics, prognostic biomarkers and systemic therapy strategies sharply reduce the need for surgery in melanoma.mp4\u003c\/p\u003e\n\u003cp\u003eKEYNOTE LECTURE KEY06 Improving outcomes in melanoma beyond the standard use of immune checkpoint blockers.mp4\u003c\/p\u003e\n\u003cp\u003eOpening Ceremony.mp4\u003c\/p\u003e\n\u003cp\u003eSATELLITE SYMPOSIUM SAT01 Platinum Sponsor.mp4\u003c\/p\u003e\n\u003cp\u003eSATELLITE SYMPOSIUM SAT02 Gold Sponsor.mp4\u003c\/p\u003e\n\u003cp\u003eSATELLITE SYMPOSIUM SAT03 Silver Sponsor.mp4\u003c\/p\u003e\n\u003cp\u003eSATELLITE SYMPOSIUM SAT04 Silver Sponsor.mp4\u003c\/p\u003e\n\u003cp\u003eSATELLITE SYMPOSIUM SAT05 Further Sponsor.mp4\u003c\/p\u003e\n\u003cp\u003eSATELLITE SYMPOSIUM SAT06 Further Sponsor.mp4\u003c\/p\u003e\n\u003cp\u003eSATELLITE SYMPOSIUM SAT07 Silver Sponsor.mp4\u003c\/p\u003e\n\u003cp\u003eSATELLITE SYMPOSIUM SAT08 Gold Sponsor.mp4\u003c\/p\u003e\n\u003cp\u003eSATELLITE SYMPOSIUM SAT09 Further Sponsor.mp4\u003c\/p\u003e\n\u003cp\u003eSATELLITE SYMPOSIUM SAT10 Platinum Sponsor.mp4\u003c\/p\u003e\n\u003cp\u003eSATELLITE SYMPOSIUM SAT11 Further Sponsor.mp4\u003c\/p\u003e\n\u003cp\u003eSOCRATES’ DIALOGUES I- AN INTERACTIVE MORNING SESSION The role of microbiome for immunotherapies.mp4\u003c\/p\u003e\n\u003cp\u003eSOCRATES’ DIALOGUES II- AN INTERACTIVE MORNING SESSION Treatment refractory stage IV melanomas- what do I do.mp4\u003c\/p\u003e\n\u003cp\u003eSOCRATES’ DIALOGUES III- AN INTERACTIVE MORNING SESSION Women in dermato-oncology.mp4\u003c\/p\u003e\n\u003cp\u003eSOCRATES’ DIALOGUES IV- AN INTERACTIVE MORNING SESSION Prognostic and predictive biomarkers for melanoma.mp4\u003c\/p\u003e\n\u003cp\u003eSOCRATES’ DIALOGUES V- AN INTERACTIVE MORNING SESSION Challenges in neoadjuvant therapy.mp4\u003c\/p\u003e\n\u003cp\u003eSOCRATES’ DIALOGUES VI- AN INTERACTIVE MORNING SESSION How to build up a career in dermato-oncology.mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY03 Prognostic and predictive biomarkers in melanoma.mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY08 Intralesional therapies of skin cancer.mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY09 Liquid biopsy as a decision maker in melanoma.mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY15 Neoadjuvant treatment of melanoma.mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY16 Melanoma guidelines around the world.mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY17 Immunotherapy of Merkel cell carcinoma.mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY20 Registries for real world treatment data and outcome research.mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY21 Memorial Symposium for Jeff Weber Drug resistance to immune checkpoint inhibition.mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY22 Skin Care in Organ Transplant Patients Europe (SCOPE).mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY23 Melanoma research.mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY25 Management of mucosal melanoma.mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY28 Drug resistance to targeted therapies.mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY29 Molecular tumor board for skin cancers.mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY30 Treatment of field cancerization including actinic cheilitis.mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY31 Adjuvant treatment of melanoma.mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY32 Management of brain metastasis.mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY34 Surgical pearls in the treatment of skin cancer.mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY35 Rare skin tumors (adnexal, sebaceous, DFSP).mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY36 Global epidemiologic trends and survival in skin cancer.mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY41 Mohs micrographic surgery and skin cancer management.mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY45 Primary prevention of skin cancer.mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY46 Is there a future for sentinel node biopsy.mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY47 Patient Advocacy Groups.mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY49 New devices for ..mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY53 Treatment at the end of the life.mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY54 Management of adverse events in targeted therapies.mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY55 Management of lentigo maligna and acral lentiginous melanomas.mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY56 Immune checkpoint inhibition in immunocompromised patients.mp4\u003c\/p\u003e\n\u003cp\u003eSYMPOSIUM SY65 Genetic susceptibility of melanoma and cancer syndromes.mp4\u003c\/p\u003e","brand":"Medicalcoursespro","offers":[{"title":"Default Title","offer_id":46405783748804,"sku":null,"price":91.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0751\/7644\/4100\/files\/European-Association-of-Dermato-Oncology-11th-World-Congress-of-Melanoma-and-21st-EADO-Congress-2025.jpg?v=1784216101","url":"https:\/\/medicalcoursespro.com\/products\/european-association-of-dermato-oncology-11th-world-congress-of-melanoma-and-21st-eado-congress-2025","provider":"Medicalcoursespro","version":"1.0","type":"link"}